GlassScriptPhysician profile
Eric Christopher Szillus
NPI 1891082061
$6,289.56
in general payments reported to CMS, 2019-2025
25 companies · $42.79 in 2025
The $42.79 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,813 · 2022: $2,369 · 2023: $1,796 · 2024: $269 · 2025: $42.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,937 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,937.21 |
| Education | $170.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,179.67 | 2021-2023 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $1,085.14 | 2021-2024 | Fasenra, Tezspire, Breztri |
| Glaxosmithkline, LLC. | $772.27 | 2021-2024 | Trelegy Ellipta, Nucala |
| Genzyme Corporation | $455.02 | 2021-2023 | |
| Grifols USA, LLC | $428.33 | 2021-2024 | Prolastin-C Liquid |
| Amgen INC. | $358.73 | 2021-2024 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $342.46 | 2021-2024 | Dupixent |
| Electromed, INC. | $278.76 | 2022-2024 | Smartvest |
| Baxter Healthcare | $271.71 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Teva Pharmaceuticals USA, INC. | $170.07 | 2022 | |
| Mylan Specialty L.P. | $157.05 | 2021-2023 | Yupelri |
| Advanced Respiratory, INC | $143.35 | 2021 | |
| Mallinckrodt Hospital Products INC. | $96.21 | 2022-2023 | Acthar |
| Sanofi-Aventis U.S. LLC | $94.95 | 2023 | |
| Covis Pharma Gmbh | $82.96 | 2022-2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apria Healthcare LLC | $69.78 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $65.62 | 2023-2024 | Aralast |
| Inogen, INC. | $45.68 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Cvrx, INC. | $42.79 | 2025 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $42.37 | 2021 | |
| Philips North America LLC | $31.64 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $22.55 | 2021 | |
| Phadia US INC. | $19.54 | 2023 | Immunocap |
| Gilead Sciences, INC. | $19.24 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.67 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Szillus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.